CHEK2 and cancer: The ATM-Chk2 pathway frequently has mutations or decreased expression, not only in hereditary cases, but also in many types of cancers, such as endometrial cancer, breast cancer, pancreas cancer, head and neck squamous cell cancer, and non-small-cell lung cancer.